# FDA Inspection 1068986 - Central Pennsylvania Blood Bank Headquarters - August 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/f10a14ce-49e2-4803-bce3-737254222bce
Source feed: FDA_Inspections

> FDA Inspection 1068986 for Central Pennsylvania Blood Bank Headquarters on August 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068986
- Company Name: Central Pennsylvania Blood Bank Headquarters
- Inspection Date: 2018-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1222397 - 2023-10-19](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/61ee401c-e4b4-45c4-951f-e9dea52dcb17)
- [FDA Inspection 1179906 - 2022-09-01](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/7c9a69a8-88be-41d8-ace5-c55e8ffa3adb)
- [FDA Inspection 1179906 - 2022-09-01](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/b5bbb691-ac48-4a3e-868d-faa17e9cde69)
- [FDA Inspection 961421 - 2016-02-26](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/70b44e87-1c1c-4f04-b63e-704c23257ed3)
- [FDA Inspection 869762 - 2014-03-13](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank-headquarters/501e5d02-46ef-45fa-8ef6-d981fee5c91a)

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank-headquarters/38fcc2fb-766a-4032-a720-565cf3e3b20e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d